Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold

British Journal of Pharmacology

Volumn 168, Issue 2, 2013, Pages 354-362

  Manni, Maria Elena ^a   De Siena, Gaetano ^a   Saba, Alessandro ^b   Marchini, Maja ^b   Landucci, Elisa ^a   Gerace, Elisabetta ^a   Zazzeri, Marina ^a   Musilli, Claudia ^a   Pellegrini Giampietro, Domenico ^a   Matucci, Rosanna ^a   Zucchi, Riccardo ^b   Raimondi, Laura ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

3 iodothyronamine; object recognition task; pain threshold; passive avoidance; thyroid hormones

Indexed keywords

3 IODOTHYRONAMINE; CLORGYLINE; HORMONE DERIVATIVE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C FOS; THYROXINE; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; GLUCOREFRACTOMETER; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOT PLATE TEST; LATENT PERIOD; LEARNING; LICKING; MALE; MEMORY CONSOLIDATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; VISUAL MEMORY; WESTERN BLOTTING;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; HOT TEMPERATURE; MALE; MAP KINASE SIGNALING SYSTEM; MEMORY; MICE; PAIN; PAIN THRESHOLD; THYROID HORMONES; THYRONINES;

EID: 84871583864     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02137.x     Document Type: Article

References (37)

1. Bauer M, Goetz T, Glenn T, Whybrow PC, (2008). The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 20: 1101-1114.
2. Chen G, Chen P, Tan H, Ma D, Dou F, Feng J, et al,. (2008). Regulation of the NMDA receptor-mediated synaptic response by acetylcholinesterase inhibitors and its impairment in an animal model of Alzheimer's disease. Neurobiol Aging 29: 1795-1804.
3. Dhillo WS, Bewick GA, White NE, Gardiner JV, Thompson EL, Bataveljic A, et al,. (2008). The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes Obes Metab 11: 251-260.
4. Doyle KP, Suchland KL, Ciesielski TM, Lessov NS, Grandy DK, Scanlan TS, et al,. (2007). Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38: 2569-2576.
5. Ennaceur A, Delacour J, (1988). A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31: 47-59.
6. Escobar-Morreale HF, Escobar del Rey F, Obregon MJ, Morreale de Escobar G, (1996). Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rats. Endocrinology 137: 2490-2502.
7. Galeotti N, Bartolini A, Ghelardini C, (2006). Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. Neuropharmacology 50: 309-316.
8. Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, et al,. (2012). Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab 97: E69-E74.
9. Guasti L, Marino F, Cosentino M, Cimpanelli M, Rasini E, Piantanida E, et al,. (2007). Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment. Clin J Pain 23: 518-523.
10. Haley TJ, McCormick WG, (1957). Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12: 12-15.
11. Hu HJ, Alter BJ, Carrasquillo Y, Qiu CS, Gereau RW, 4th (2007). Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J Neurosci 27: 13181-13191.
12. Jarvik ME, Kopp R, (1967). An improved one-trial passive avoidance learning situation. Psychol Rep 21: 221-224.
13. Ji RR, Gereau RW, 4th, Malcangio M, Strichartz GR, (2009). MAP kinase and pain. Brain Res Rev 60: 135-148.
14. Kida S, Josselyn SA, Peña de Ortiz S, Kogan JH, Chevere I, Masushige S, et al,. (2002). CREB required for the stability of new and reactivated fear memories. Nat Neurosci 5: 348-355.
15. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
16. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, et al,. (2009). Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 201: 377-386.
17. Liu L, Ji F, Liang J, He H, Fu Y, Cao M, (2012). Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury. Brain Res 1427: 1-9.
18. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
19. Manni ME, De Siena G, Saba A, Marchini M, Bigagli E, Cinci L, et al,. (2012). 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse. Br J Pharmacol 166: 650-658.
20. Peng S, Zhang Y, Ren B, Zhang J, Wang H, (2011). Effect of ketamine administration on memory consolidation, p-CREB and c-fos expression in the hippocampal slices of minor rats. Mol Biol Rep 38: 2401-2407.
21. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B, et al,. (2008). Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149: 3037-3045.
22. Piehl S, Hoefig CS, Scanlan TS, Köhrle J, (2011). Thyronamines-past, present, and future. Endocr Rev 32: 64-80.
23. Pietsch CA, Scanlan TS, Anderson RJ, (2007). Thyronamines are substrates for human liver sulfotransferases. Endocrinology 148: 1921-1927.
24. Pinna G, Brödel O, Visser T, Jeitner A, Grau H, Eravci M, et al,. (2002). Concentrations of seven iodothyronine metabolites in brain regions and the liver of the adult rat. Endocrinology 143: 1789-1800.
25. Pittenger C, Huang YY, Paletzki RF, Bourtchouladze R, Scanlin H, Vronskaya S, et al,. (2002). Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 34: 447-462.
26. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, et al,. (2007). Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117: 4034-4043.
27. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, et al,. (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108: 8485-8490.
28. Rivas M, Naranjo JR, (2007). Thyroid hormones, learning and memory. Genes Brain Behav 6 (Suppl 1): 40-44. Review.
29. Roberson ED, Sweatt JD, (1999). A biochemical blueprint for long-term memory. Learn Mem 6: 381-388. Review.
30. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, et al,. (2010). Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151: 5063-5073.
31. Sampaolo S, Campos-Barros A, Mazziotti G, Carlomagno S, Sannino V, Amato G, et al,. (2005). Increased cerebrospinal fluid levels of 3,3',5'- triiodothyronine in patients with Alzheimer's disease. J Clin Endocrinol Metab 90: 198-202.
32. Scanlan TS, (2009). Minireview: 3-iodothyronamine (T1AM): a new player on the thyroid endocrine team? Endocrinology 150: 1108-1111.
33. Schicho R, Liebmann I, Lippe IT, (2005). Extracellular signal-regulated kinase-1 and -2 are activated by gastric luminal injury in dorsal root ganglion neurons via N-methyl-D-aspartate receptors. Neuroscience 134: 505-514.
34. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards RH, Scanlan TS, (2007). Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem Biol 2: 390-398.
35. Whitaker-Azmitia PM, Zhang X, Clarke C, (1994). Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology 11: 125-132.
36. Wood WJ, Geraci T, Nilsen A, DeBarber AE, Scanlan TS, (2009). Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo. Chembiochem 10: 361-365.
37. Zucchi R, Chiellini G, Scanlan TS, Grandy DK, (2006). Trace amine-associated receptors and their ligands. Br J Pharmacol 149: 967-978.